FDA Approved: CYCLOPHOSPHAMIDE — Supplemental Application (Civica, Inc.)

View source ↗

Summary

FDA approved a supplemental application for cyclophosphamide from Civica, Inc. under ANDA 040745.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Breast Cancer
• Hodgkin Lymphoma
• Multiple Myeloma
• Non-hodgkin Lymphoma
• Ovarian Cancer
• Retinoblastoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)

Snippet

SUPPL AP for CYCLOPHOSPHAMIDE (CYCLOPHOSPHAMIDE)